Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Scharn

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Organic Letters|November 9, 2002
Borane-ammonia complexes stabilized by hydrogen bondingChambers C Hughes, Dirk Scharn, Johann Mulzer, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activityKarsten Schnatbaum, Elsa Locardi, Dirk Scharn, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2009
Discovery of orally available integrin alpha5beta1 antagonistsGunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonistsGunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Journal of Medicinal Chemistry|June 26, 2009
Novel small molecule bradykinin B2 receptor antagonistsChristoph Gibson, Karsten Schnatbaum, Jochen R Pfeifer, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocyclesGunther Zischinsky, Roland Stragies, Marco Schaudt, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazidesMarco Schaudt, Elsa Locardi, Gunther Zischinsky, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2009
Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivativesKarsten Schnatbaum, Marco Schaudt, Roland Stragies, et al.
Oncogene|March 2, 2018
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AMLDaniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, et al.
European Journal of Medicinal Chemistry|July 4, 2012
Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligandsHarald Engelhardt, Iwan J P de Esch, Daniel Kuhn, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Organic Letters|November 9, 2002
Borane-ammonia complexes stabilized by hydrogen bondingChambers C Hughes, Dirk Scharn, Johann Mulzer, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2006
Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activityKarsten Schnatbaum, Elsa Locardi, Dirk Scharn, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2009
Discovery of orally available integrin alpha5beta1 antagonistsGunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonistsGunther Zischinsky, Frank Osterkamp, Doerte Vossmeyer, et al.
Journal of Medicinal Chemistry|June 26, 2009
Novel small molecule bradykinin B2 receptor antagonistsChristoph Gibson, Karsten Schnatbaum, Jochen R Pfeifer, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocyclesGunther Zischinsky, Roland Stragies, Marco Schaudt, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Novel small molecule bradykinin B1 receptor antagonists. Part 1: benzamides and semicarbazidesMarco Schaudt, Elsa Locardi, Gunther Zischinsky, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2009
Novel small molecule bradykinin B1 receptor antagonists. Part 3: hydroxyurea derivativesKarsten Schnatbaum, Marco Schaudt, Roland Stragies, et al.
Oncogene|March 2, 2018
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AMLDaniel Gerlach, Ulrike Tontsch-Grunt, Anke Baum, et al.
European Journal of Medicinal Chemistry|July 4, 2012
Detailed structure-activity relationship of indolecarboxamides as H4 receptor ligandsHarald Engelhardt, Iwan J P de Esch, Daniel Kuhn, et al.
Pageof 2